Tirzepatide
A dual GLP-1/GIP receptor agonist peptide used in research models studying combined incretin signaling.
Tirzepatide is a dual-agonist peptide acting on both GLP-1 and GIP receptors, widely used in metabolic research to study combined incretin signaling and energy-balance pathways. Supplied as a research-grade compound across four dosage strengths, each independently tested: 10mg (99.709% purity, Janoshik), 20mg (99.639% purity, Janoshik), 30mg (>99.9% purity, 101.1% potency, Krause Analytical), and 60mg (99.914% purity, Janoshik). Not a prescription medication and not labeled, dosed, or sold for human or animal use. See Lab Reports page for certificates.
For laboratory research use only. Not for human or veterinary use, and not for use in diagnostic procedures.
| Attributes | Value |
|---|---|
| Size |
10mg, 20mg, 30mg, 60mg |
Frequently bought together
-
BPC-157
Price range: $42.00 through $72.00 -
GHK-Cu
Price range: $58.00 through $96.00 -
Melanotan 1
Price range: $38.00 through $64.00 -
Retatrutide
Price range: $165.00 through $280.00 -
Semaglutide
Price range: $125.00 through $210.00 -
TB-500
Price range: $48.00 through $80.00